Company PREDILIFE

Equities

ALPRE

FR0010169920

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Company contact information

Sector

Sales per Business

Sales per region

Annual profits - Rate of surprise

Sector Bio Diagnostics & Testing

Market Closed - Euronext Paris Other stock markets 09:33:19 2024-05-02 am EDT			5-day change	1st Jan Change
15.9 ^EUR	+208.74%		+285.92%	+178.95%

2023	Predilife: a project accredited by Finance Innovation	CF
2023	Predilife S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	CI

PREDILIFE specializes in the development of predictive tests, particularly in the field of oncology. The company has MammoRisk®, a breast cancer predictive test that uses a first mammogram and a few questions to obtain a first risk assessment. A genetic test then makes it possible to estimate the risk of breast cancer more accurately. The technology used by MammoRisk® makes it possible to evaluate, from a database of individuals monitored over time, the risks of an individual compared to the future of his « closest » neighbours thanks to a database of over 1,000,000 American women,over 300,000 French women and 500,000 English.

Number of employees: 20

EUR in Million	2021	Weight	Weight	Delta
Predictive Health Checks with Companies 49.9 %	-	-	49.9 %	-
Predictive Health Checks with Health Professionals and Hospitals 46.2 %	-	-	46.2 %	-
Training Courses 3.9 %	-	-	3.9 %	-

EUR in Million	2021	Weight	Weight	Delta
France 70.0 %	0	100.0 %	70.0 %	+42.28%
Italy 27.8 %	-	-	27.8 %	-
Belgium 1.5 %	-	-	1.5 %	-
Greece 0.7 %	-	-	0.7 %	-

Managers	Title	Age	Since
Stéphane Ragusa CEO	Chief Executive Officer	53	03-12-31
Émilien Gauthier CTO	Chief Tech/Sci/R&D Officer	-	06-12-31
Marion Renelier LAW	General Counsel	-	15-12-31
Anne Kerzan SAM	Sales & Marketing	-	21-12-31
Elise Tronel SAM	Sales & Marketing	-	21-08-31

Members of the board	Title	Age	Since
Charles Vilgrain BRD	Director/Board Member	44	17-12-31
Stéphane Ragusa CEO	Chief Executive Officer	53	03-12-31
Antoine Bricard BRD	Director/Board Member	56	17-12-31
Ombline de Villèle BRD	Director/Board Member	49	17-12-31

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	3,720,277	3,444,544 ( 92.59 %)	20,740 ( 0.5575 %)	92.59 %

Predilife SA

39, rue Camille Desmoulins

94805, Villejuif

+33 09 72 22 67 08

http://www.predilife.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
PREDILIFE	+178.95%	20.36M
EXACT SCIENCES CORPORATION	-18.16%	11.03B
IOVANCE BIOTHERAPEUTICS, INC.	+58.43%	3.5B
GUARDANT HEALTH, INC.	-31.31%	2.23B
BGI GENOMICS CO., LTD.	-14.31%	2.16B
VERACYTE, INC.	-26.61%	1.54B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+34.35%	1.12B
SEEGENE, INC.	-3.28%	737M
CAREDX, INC	-22.75%	477M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-40.20%	411M

Bio Diagnostics & Testing